Phase I Study of Perillyl Alcohol in Patients with Refractory Malignancies

We treated 21 patients in a dose-finding and pharmacokinetic study of the monoterpene perillyl alcohol with the drug given orally in 3 divided doses on a chronic basis. The average number of days that patients remained on study was 48 (range 11-172). Fatigue and low-grade nausea were dose limiting....

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer biology & therapy 2002-03, Vol.1 (2), p.124-129
Hauptverfasser:	Kathleen Peccerillo, Giuseppe Pizzorno, Peter T. C. Ho, Walter McMurray, John R. Murren, Barbara A. Burtness, Thomas Rutherford, Ashwin Gollerkari, Xin Li, Susan A. DiStasio, Anne McKeon, Alan Sartorelli
Format:	Artikel
Sprache:	eng
Schlagworte:	Binding Biology Bioscience Calcium Cancer Cell Cycle Landes Organogenesis Proteins
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!